MESO earnings date and last-quarter result: next report 2026-09-04, last quarter miss, P/E -22.06. Updated 2026-07-23.
Mesoblast (MESO) Research Hub
Mesoblast (MESO) trades on NASDAQ, AU in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 12.39 USD (+0.90%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -22.06, market cap 2.12B. This hub links to the full technical, earnings and options research available for MESO.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, AU |
| Last close | 12.39 USD (+0.90%) |
| 52-week range | 11.89 USD – 19.36 USD |
| Trend regime | Range |
| 14-day RSI | 38.4 (Bearish) |
| Trailing P/E | -22.06 |
| Market cap | 2.12B |
| Dividend yield | 0.00% |
| Next earnings | 2026-09-04 |
Available research for MESO
Covered Call on MESO: how it works, illustrative setup around the real 12.39 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MESO: how it works, illustrative setup around the real 12.39 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MESO: how it works, illustrative setup around the real 12.39 USD price, max profit/loss, breakeven and when to use it. Educational.
MESO technical analysis: range, last 12.39 USD, RSI 38.4, 52w range 11.89 USD–19.36 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is MESO in?
Mesoblast (MESO) is classified under Healthcare (Biotechnology), listed on NASDAQ, AU.
Is MESO in an uptrend or downtrend?
As of 2026-10-26, MESO is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MESO's trailing P/E ratio?
MESO's trailing P/E is -22.06, with a market cap of 2.12B. See the earnings research page for full valuation detail.
When does MESO next report earnings?
MESO is next scheduled to report earnings on 2026-09-04.